Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $145.56 | 3 | 67.7% |
| Food and Beverage | $69.34 | 2 | 32.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NeoTract Inc. | $110.00 | 1 | $0 (2017) |
| PORTOLA PHARMACEUTICALS, INC. | $55.77 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $35.56 | 2 | $0 (2020) |
| Boston Scientific Corporation | $13.57 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $13.57 | 1 | Boston Scientific Corporation ($13.57) |
| 2020 | $20.04 | 1 | Astellas Pharma US Inc ($20.04) |
| 2018 | $71.29 | 2 | PORTOLA PHARMACEUTICALS, INC. ($55.77) |
| 2017 | $110.00 | 1 | NeoTract Inc. ($110.00) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2022 | Boston Scientific Corporation | rezum Generator (Device) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: rezum_URO | ||||||
| 02/06/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Education | In-kind items and services | $20.04 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Education | In-kind items and services | $15.52 | General |
| Category: ONCOLOGY | ||||||
| 03/13/2018 | PORTOLA PHARMACEUTICALS, INC. | BEVYXXA (Drug) | Food and Beverage | In-kind items and services | $55.77 | General |
| Category: CARDIOLOGY/HEMATOLOGY | ||||||
| 12/06/2017 | NeoTract Inc. | Urolift - UL400 (Device) | Education | In-kind items and services | $110.00 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,165 | 1,708 | $483,365 | $82,044 |
| 2022 | 15 | 1,800 | 2,649 | $624,049 | $134,491 |
| 2021 | 19 | 2,075 | 3,268 | $685,426 | $175,512 |
| 2020 | 19 | 2,220 | 3,396 | $569,731 | $169,258 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 298 | 435 | $123,975 | $22,061 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 222 | $89,022 | $16,688 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 182 | 246 | $70,110 | $10,678 | 15.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 12 | 69 | $44,436 | $9,268 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 108 | 136 | $54,536 | $9,119 | 16.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 41 | 58 | $44,080 | $6,846 | 15.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $12,624 | $2,532 | 20.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 30 | 40 | $30,400 | $2,274 | 7.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 220 | 355 | $3,195 | $1,101 | 34.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 12 | 23 | $2,346 | $549.78 | 23.4% |
| 51702 | Simple insertion of temporary bladder tube | Facility | 2023 | 13 | 26 | $5,044 | $503.10 | 10.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Facility | 2023 | 19 | 21 | $1,491 | $141.96 | 9.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 18 | 22 | $1,562 | $138.86 | 8.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 14 | 15 | $480.00 | $116.85 | 24.3% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 12 | 16 | $64.00 | $26.98 | 42.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 308 | 428 | $160,500 | $36,527 | 22.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 38 | 209 | $125,818 | $29,463 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 396 | 502 | $133,532 | $27,577 | 20.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 67 | 88 | $62,480 | $12,794 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 66 | 83 | $31,125 | $6,288 | 20.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 114 | 122 | $32,452 | $6,073 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $21,648 | $4,782 | 22.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 573 | 920 | $7,360 | $2,871 | 39.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 13 | $6,903 | $1,763 | 25.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 38 | 67 | $6,365 | $1,488 | 23.4% |
About Dr. James Stille, MD
Dr. James Stille, MD is a Urology healthcare provider based in Youngstown, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417964610.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Stille, MD has received a total of $214.90 in payments from pharmaceutical and medical device companies, with $13.57 received in 2022. These payments were reported across 5 transactions from 4 companies. The most common payment nature is "Education" ($145.56).
As a Medicare-enrolled provider, Stille has provided services to 7,260 Medicare beneficiaries, totaling 11,021 services with total Medicare billing of $561,306. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Youngstown, OH
- Active Since 08/01/2006
- Last Updated 06/04/2008
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1417964610
Products in Payments
- Urolift - UL400 (Device) $110.00
- BEVYXXA (Drug) $55.77
- XTANDI (Drug) $35.56
- rezum Generator (Device) $13.57
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Youngstown
Dr. Mark Memo, D.o, D.O
Urology — Payments: $15,280
Dr. Vincent Ricchiuti, M.d, M.D
Urology — Payments: $8,827
Dr. Daniel Ricchiuti, M.d, M.D
Urology — Payments: $7,533
Robert Ricchiuti, M.d, M.D
Urology — Payments: $3,231
Lauren Kegelmyer
Urology — Payments: $476.62
Paul Musselman, Md, MD
Urology — Payments: $244.77